The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

February 2021

Some drugs won’t be payable when administered by a health care provider to Blue Cross and BCN commercial members

For dates of service on or after April 1, 2021, the medications listed below won’t be payable by Blue Cross Blue Shield of Michigan and Blue Care Network when administered by a physician or other health care professional.

This change affects Blue Cross commercial and Blue Care Network commercial members. The reason for the change is that these drugs can safely and conveniently be self-administered by the member in the member’s home. They don’t require administration by a health care professional.

The following drugs are currently payable under either the medical benefit or the pharmacy benefit. Starting April 1, they’re payable only under the pharmacy benefit.

  • Actimmune® (interferon gamma-1b), HCPCS code J9216
  • Akynzeo® (netupitant / palonosetron), HCPCS code J8655
  • Arcalyst® (rilonacept), HCPCS code J2793
  • Banophen™ / Ormir™ / Pharbedrylâ„¢ (diphenhydramine), HCPCS code Q0163
  • Emend® (aprepitant), HCPCS code J8501
  • Imitrex® (sumatriptan succinate), HCPCS code J3030
  • Granisetron HCl® (granisetron hydrochloride), HCPCS code Q0166 / S0091
  • Marinol® / Syndros® (dronabinol), HCPCS code Q0167
  • Megestrol acetate®, HCPCS code S0179
  • Pegasys® (peginterferon alfa-2a), HCPCS code S0145
  • Pegintron® (peginterferon alfa-2b), HCPCS code S0148
  • Promethazine HCl® (phenadoz), HCPCS code Q0169
  • Regranex® (becaplermin), HCPCS code S0157
  • Sensipar® (cinacalcet), HCPCS code J0604
  • Varubi® (rolapitant), HCPCS code J8670
  • Zofran® / Zuplenz® (ondansetron), HCPCS code Q0162 / S0119

There are no other changes that apply to the management of these therapies at this time.

For more information

To view requirements for drugs covered under the pharmacy benefit, see the Blue Cross and BCN Prior authorization and step therapy coverage criteria document. This document is available from the following pages on the ereferrals.bcbsm.com website:

For a list of requirements related to drugs covered under the medical benefit, see the Blue Cross and BCN utilization management medical drug list for Blue Cross PPO (commercial) and BCN HMO (commercial) members document.

We’ll update the requirements lists with the new information prior to April 1, 2021.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2020 American Medical Association. All rights reserved.